HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Florencio M Ubeira Selected Research

Anisakiasis

10/2020Author Correction: Analysis of Ani s 7 and Ani s 1 allergens as biomarkers of sensitization and allergy severity in human anisakiasis.
1/2020Analysis of Ani s 7 and Ani s 1 allergens as biomarkers of sensitization and allergy severity in human anisakiasis.
2/2014Anti-Anisakis IgE seroprevalence in the healthy Croatian coastal population and associated risk factors.
6/2011Synergism between prior Anisakis simplex infections and intake of NSAIDs, on the risk of upper digestive bleeding: a case-control study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Florencio M Ubeira Research Topics

Disease

7Infections
01/2016 - 09/2004
4Hypersensitivity (Allergy)
01/2022 - 02/2014
4Anisakiasis
10/2020 - 06/2011
4Fascioliasis
05/2018 - 08/2003
3Parasitic Diseases (Parasitic Disease)
04/2014 - 09/2004
2Tics (Tic)
05/2011 - 04/2011
1Growth Disorders
01/2018
1Septic Shock (Toxic Shock Syndrome)
01/2016
1Inflammation (Inflammations)
01/2016
1Bacterial Infections (Bacterial Infection)
01/2016
1Shock
01/2016
1Neoplasms (Cancer)
04/2014
1Chronic Urticaria
06/2013
1Urticaria (Hives)
06/2013
1Leishmaniasis
01/2013
1Hemorrhage
06/2011
1Cardiotoxicity
05/2010
1Drug-Related Side Effects and Adverse Reactions
05/2010
1Trichinellosis
09/2004
1Atherosclerotic Plaque (Atheroma)
06/2004

Drug/Important Bio-Agent (IBA)

6AntigensIBA
01/2018 - 08/2003
5AllergensIBA
01/2022 - 06/2011
5Proteins (Proteins, Gene)FDA Link
01/2016 - 08/2003
4Pharmaceutical PreparationsIBA
06/2011 - 05/2010
3Biomarkers (Surrogate Marker)IBA
10/2020 - 05/2010
3Immunoglobulin E (IgE)IBA
01/2020 - 03/2006
3AntibodiesIBA
08/2011 - 03/2006
2CathepsinsIBA
05/2018 - 01/2016
2LipopolysaccharidesIBA
01/2016 - 06/2004
2CytokinesIBA
06/2013 - 06/2004
2EnzymesIBA
05/2010 - 09/2004
2Monoclonal AntibodiesIBA
02/2007 - 09/2004
1ElectrolytesIBA
01/2016
1Carrier Proteins (Binding Protein)IBA
01/2016
1Indicators and Reagents (Reagents)IBA
01/2016
1Blood Proteins (Serum Proteins)IBA
01/2016
1Lipid AIBA
01/2016
1AnthelminticsIBA
01/2016
1Peptides (Polypeptides)IBA
01/2016
1LectinsIBA
04/2014
1isoquinolineIBA
01/2013
1AlkaloidsIBA
01/2013
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
06/2011
1IsoenzymesIBA
02/2011
1ProteomeIBA
05/2010
1Immunoglobulin G (IgG)IBA
03/2006
1Phosphopyruvate Hydratase (Enolase)IBA
03/2006
1tyveloseIBA
09/2004
1ImmunosorbentsIBA
09/2004
1LigandsIBA
06/2004
1NF-kappa B (NF-kB)IBA
06/2004
1Interleukin-1 (Interleukin 1)IBA
06/2004
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
06/2004
1Interleukin-12 (IL 12)IBA
06/2004
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
06/2004
1Chemokine CCL5IBA
06/2004
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
06/2004
1Dihydrotachysterol (AT 10)IBA
06/2004
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
06/2004
1Toll-Like Receptors (Toll-Like Receptor)IBA
06/2004
1Receptor-Interacting Protein Serine-Threonine KinasesIBA
06/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2004
1Interleukin-6 (Interleukin 6)IBA
06/2004
1Macrophage Colony-Stimulating FactorIBA
06/2004
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
06/2004
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2004

Therapy/Procedure

1Drug Therapy (Chemotherapy)
06/2011